Algorhythm Holdings
RIME
8 hedge funds and large institutions have $308K invested in Algorhythm Holdings in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
52% more capital invested
Capital invested by funds: $203K → $308K (+$106K)
14% more funds holding
Funds holding: 7 → 8 (+1)
0.01% more ownership
Funds ownership: 0.02% → 0.04% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
+$97.2K |
| 2 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
+$55.2K |
| 3 |
Two Sigma Investments
New York
|
+$47.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$20.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$287 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$133 |
RIME Hedge Fund Activity: Q3 2023 in Review
8 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Algorhythm Holdings (RIME) for Q3 2023, worth a combined $308K — up 52% from $203K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new RIME positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Two Sigma Advisers, opening a new position worth an estimated $97.2K. The largest seller was UBS Group, exiting entirely with an estimated $133 sold.
- 8 institutional investors held Algorhythm Holdings (RIME) as of Q3 2023, up from 7 in Q2 2023.
- Funds reported $308K of Algorhythm Holdings stock for Q3 2023, up 52% quarter-over-quarter.
- 3 funds opened new Algorhythm Holdings positions in Q3 2023 and 1 closed out, a net change of +2 holders.
- The largest Algorhythm Holdings buyer in Q3 2023 was Two Sigma Advisers, an estimated $97.2K added.
- The largest Algorhythm Holdings seller in Q3 2023 was UBS Group, an estimated $133 sold.
Based on aggregated 13F filings for Q3 2023.